CJC-1295 No DAC + Ipamorelin

This combination pairs CJC-1295 (no DAC), a GHRH analogue, with ipamorelin, a selective growth hormone secretagogue, to produce a synergistic dual stimulus for GH release. CJC-1295 amplifies the baseline GH pulse via GHRH receptor activation, while ipamorelin simultaneously activates the ghrelin/GHS receptor pathway — the two signals acting together to produce a stronger, more pronounced GH response than either compound alone. Ipamorelin’s selectivity means it does not significantly elevate cortisol or prolactin, making this a well-regarded combination in GH axis research.